Metronomic capecitabine inhibits liver transplant rejection in rats by triggering recipients' T cell ferroptosis
Frontiers | Cost-effectiveness analysis of metronomic capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma
![PDF] Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/957fa2625a87315f5d56f5911f5b8b269f747b86/6-Table2-1.png "PDF] Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future? | Semantic Scholar")
PDF] Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future? | Semantic Scholar
JCM | Free Full-Text | Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows
Overall survival of metronomic capecitabine and best supportive care... | Download Scientific Diagram
PDF) Metronomic capecitabine as maintenance treatment after first line induction with XELOX for metastatic colorectal cancer patients
Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation | SpringerLink
JCM | Free Full-Text | Metronomic Chemo-Endocrine Therapy (FulVEC) as a Salvage Treatment for Patients with Advanced, Treatment-Refractory ER+/HER2-Breast Cancer—A Retrospective Analysis of Consecutive Patients Data
Metronomic capecitabine maintenance extends DFS in triple-negative breast cancer
JCI Insight - Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells
PDF) A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer
Metronomic Chemotherapy for Triple-Negative Breast Cancer
A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer | Trials | Full Text
JCI Insight - Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells
Camrelizumab and metronomic capecitabine for patients with treatment-refractory solid tumors (McCREST trial) | Future Oncology
Metronomic chemotherapy in breast cancer | Semantic Scholar
A phase II study of a doublet metronomic chemotherapy regimen consisting of oral vinorelbine and capecitabine in Chinese women with HER2‐negative metastatic breast cancer - Chai - Thoracic Cancer - Wiley Online Library
PDF) Metronomic Capecitabine in Advanced Hepatocellular Carcinoma Patients: A Phase II Study | Rita Golfieri and Franco Trevisani - Academia.edu
Possible immunosuppressive mechanisms of metronomic capecitabine on T... | Download Scientific Diagram
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial - The Lancet
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial - The Lancet
Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure - ScienceDirect
From palliative to curative treatment - stage IV mucinous adenocarcinoma, successfully treated with metronomic capecitabine in combination with Bevacizumab and surgery- a case report – topic of research paper in Clinical medicine.
PDF) Metronomic chemotherapy with capecitabine for metastatic colorectal cancer in very elderly patients
A phase II study of a doublet metronomic chemotherapy regimen consisting of oral vinorelbine and capecitabine in Chinese women with HER2-negative metastatic breast cancer,Thoracic Cancer - X-MOL
